The renin–angiotensin–aldosterone system is a key therapeutic target in hypertension. The latest meta-analysis of mortality reduction with angiotensin-converting enzyme (ACE) inhibitors and ...
Expert Rev Cardiovasc Ther. 2013;11(6):705-717. The authors noted a significant reduction in the relative risk (RR) of all-cause mortality of 5% (HR = 0.95; 95% CI: 0.91–1.00; p = 0.032) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback